-
@ Yahoo!
2025-02-06 06:34:36
nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhv7cr6w6s32vksgz9zg9gtt6y3l9wrezg73wquk8rc3rew4dykdqw097ny
https://s.yimg.com/uu/api/res/1.2/FeEJzg98r4guN7cDxUTqdQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/4a4201442bbdae13bc10334810e6af9a
Like its healthcare technology sector peers, Siemens Healthineers has been struggling against a Chinese anti-corruption campaign that launched July 2023. The company confirmed its 2025 full-year guidance of a comparable revenue growth of between 5% and 6% compared with 2024 and an adjusted basic earnings per share of between 2.35 euros and 2.50 euros.
https://ca.finance.yahoo.com/news/siemens-healthineers-reports-q1-revenue-061434336.html